A new study has found that when it comes to the neuroprotective abilities of diabetes medications, people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users
The collaboration aims to address longstanding challenges in access and affordability that have affected the GLP-1 category
It combines well with KPV and thymosin alpha-1, with LL-37 addressing microbial triggers while the other peptides handle immune regulation
One injection at night, a single mechanism to think about, a long track record
CrossRef Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study Jung Sun Kim, Jeffrey Wong, SanChi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon Liver International .2026;[Epub] CrossRef Integrative analyses of network pharmacology and bioinformatics reveal the synergistic antitumor effects of cantharidin and ginsenosides Rg3 on hepatocellular carcinoma Xianggang Gou, Zhongzheng Zhou, Yuehua Wang, Henye Yuan, Ziyao Wang, Jie Chen, Wei Yan, Haisheng Wang, Jia Yan Biochemical Pharmacology .2026
